文献速递胰腺与胆道疾病

20分钟促胰液素刺激内镜下胰腺功能试验的临床效用及按临床变量分层的表现研究

A study of the clinical utility of a 20-minute secretin-stimulated endoscopic pancreas function test and performance according to clinical variables.
PubMed 文献 · Gastrointest Endosc · 2017-04-03

本研究评估20分钟促胰液素刺激内镜下胰腺功能试验(ePFT)在疑诊慢性胰腺炎(CP)患者中的诊断表现,以碳酸氢盐峰值浓度(PBC)≥80 mEq/L为正常。81例中27例确诊CP,ePFT敏感度66%、特异度98%。麻醉药和质子泵抑制剂(PPI)可能影响PBC,临界结果需谨慎解读。

要点

  • ePFT诊断CP的敏感度为66%(95% CI,46.0-83.5),特异度为98%(95% CI,90.1-99.9)。
  • PBC受麻醉药和PPI使用影响,这些人群的临界结果应谨慎解读。
  • 十二指肠吸引量与PBC不相关,与当前促胰液素增强MRCP的认识相反,需进一步研究。

核心结论

  • 促胰液素给药后20分钟ePFT对CP诊断的敏感度有限。
  • CP诊断不应依赖单一检查,尤其不应仅依赖胰腺功能试验。
  • 麻醉类型、BMI和年龄不影响试验表现。
  • 麻醉药和PPI可能影响PBC,这些人群的临界结果应谨慎解读。

研究设计与样本

  • 研究纳入2010年8月至2015年10月期间在胰腺门诊因考虑全胰腺切除联合自体胰岛移植等干预而就诊、疑诊CP并接受ePFT的患者共81例。
  • 促胰液素试验剂量后静脉给予合成人促胰液素,30分钟后用咪达唑仑联合芬太尼或丙泊酚实现镇静。
  • 胃镜送达主乳头,以5分钟间隔连续抽取4份样本置于密封瓶中。
  • PBC≥80 mEq/L为正常。
  • ePFT表现与EUS、ERCP、组织学和共识诊断进行比较。

主要发现

  • 81例中27例(33%)诊断为CP。
  • 27例CP中18例ePFT异常,54例非CP中1例ePFT异常。
  • ePFT诊断CP的敏感度为66%(95% CI,46.0-83.5),特异度为98%(95% CI,90.1-99.9),阳性预测值为94.7%(95% CI,74-99.9),阴性预测值为85.5%(95% CI,74.2-93.1)。
  • ERCP与PBC的一致性普遍较差,但非CP患者均无EUS重大改变,仅3例PBC<80 mEq/L者EUS正常。
  • PBC受麻醉药和PPI使用影响。

关键数值与推荐

  • PBC≥80 mEq/L判定为正常。
  • ePFT诊断CP的敏感度为66%(95% CI,46.0-83.5),特异度为98%(95% CI,90.1-99.9)。
  • 阳性预测值为94.7%(95% CI,74-99.9),阴性预测值为85.5%(95% CI,74.2-93.1)。

临床怎么用

  • 作者认为CP诊断不应依赖单一检查,尤其不应仅依赖胰腺功能试验。
  • 作者指出麻醉药和PPI可能影响PBC,这些人群的临界结果应谨慎解读。
  • 作者认为十二指肠吸引量与PBC不相关,需进一步研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Direct pancreas juice testing of bicarbonate, lipase, or trypsin after stimulation by secretin or cholecystokinin is used to determine exocrine function, a surrogate for diagnosing chronic pancreatitis (CP). Endoscopic pancreas function tests (ePFTs), where a peak bicarbonate concentration (PBC) ≥80 mEq/L in pancreas juice is considered normal, are now used more frequently. In this ePFT, aspirates start 35 minutes after secretin administration because pancreas output peaks 30 minutes after secretagogue administration. The performance of ePFT in a cohort of patients with a presumptive diagnosis of CP referred to a pancreas clinic for consideration of an intervention including total pancreatectomy and islet autotransplantation was studied, compared with EUS, ERCP, histology, and consensus diagnosis. The effect of sedation, narcotic use, aspirate volume, body mass index, age, and proton pump inhibitors (PPIs) on test performance is reported. METHODS: After a test dose, synthetic human secretin was administered intravenously, and 30 minutes later sedation was achieved with midazolam and fentanyl or propofol. A gastroscope was advanced to the major papilla where 4 continuous aspiration samples were performed at 5-minute intervals in sealed bottles. PBC ≥80 mEq/L was normal. RESULTS: Eighty-one patients had ePFTs from August 2010 through October 2015. Twenty-seven patients (33%) were diagnosed with CP. Eighteen of the 27 patients with CP and 1 of the 54 patients without CP had an abnormal ePFT, producing a sensitivity of 66% (95% CI, 46.0-83.5), specificity 98% (95% CI, 90.1-99.9), positive predictive value 94.7% (95% CI, 74-99.9), and negative predictive value 85.5% (95% CI, 74.2-93.1). ERCP and PBC concordance was generally poor, but none of the patients without CP had major EUS changes, and only 3 patients with a PBC <80 mEq/L had a normal EUS. The PBC was affected by narcotics and PPI use. CONCLUSION: A 20-minute ePFT after secretin administration had a marginal sensitivity for diagnosis of CP. The diagnosis of CP should not rely on a single study and certainly not a PFT. The duodenal aspirate volume did not correlate with the PBC, which contrasts with current secretin-enhanced MRCP knowledge; therefore, further studies on this subject are warranted. Neither type of sedation, BMI, nor age affected test performance. Narcotics and PPIs may affect the PBC, so borderline results should be interpreted with caution in these groups.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Lara LF, Takita M, Burdick JS, et al. A study of the clinical utility of a 20-minute secretin-stimulated endoscopic pancreas function test and performance according to clinical variables. Gastrointest Endosc. 2017. PMID: 28385584. doi:10.1016/j.gie.2017.03.1532

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。